Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
Trial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial of Continuation Therapy in Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)
- Status
- COMPLETED
- Phase
- PHASE3
PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED)
- Status
- COMPLETED
- Phase
- PHASE2
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)
- Status
- COMPLETED
- Phase
- PHASE3
The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC
- Status
- TERMINATED
- Phase
- PHASE2